Stocks
Funds
Screener
Sectors
Watchlists
DMTK

DMTK - DermTech Inc Stock Price, Fair Value and News

$55.65 
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

DMTK Price Action

DMTK RSI Chart

DMTK Valuation

DMTK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

DMTK Fundamentals

DMTK Revenue

DMTK Earnings

DMTK Profitability

DMTK Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202415.7M000
202314.3M14.0M14.4M15.3M
202213.0M14.1M14.7M14.5M
20216.9M9.1M10.8M11.8M
20204.3M4.6M5.4M5.9M
20192.5M2.5M2.4M3.4M
20181.2M1.6M2.0M2.4M
20170001.7M
DMTK
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer and inflammatory diseases in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it provides research services and technology platform on a contract basis to pharmaceutical companies which use the technology for clinical trials. Further, the company develops gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways to pharmaceutical companies to develop drug products in dermatology; and develop custom gene assays to support the pharmaceutical partners. It sells its products through pathology and oncology practitioners. DermTech, Inc. is headquartered in San Diego, California.
 CEO
 WEBSITEdermtech.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES278